Opinion

Video

Future Breakthroughs: What’s Next for Bispecific Antibodies in Oncology?

Experts discuss innovations and advancements in bispecific antibodies that could transform their use in the next 5 years.

Video content above is prompted by the following:

What innovations or advancements in bispecific antibodies could transform their use in the next 5 years?

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Subscribe Now!
Related Videos
Dr James Chalmers
Related Content
Eye of the hurricane | Image Credit: EvgeniyQW - stock.adobe.com
August 21st 2025

Extreme Weather Events Heighten Risk of Nationwide Drug Shortages

Brooke McCormick
managed care cast logo
August 21st 2025

High Costs, Coverage Variability Limit Access to Incretin Mimetics for Weight Management

Brooke McCormick Stephen Lott, PharmD, MS Jonathan Gabison, MD, DABOM
FDA headquarters | Image Credit: Tada Images - stock.adobe.com
August 21st 2025

FDA Issues CRL for Vatiquinone in Friedreich Ataxia, Requests More Efficacy Data

Brooke McCormick
managed care cast logo
August 21st 2025

Five Years Later: Ongoing COVID-19 Challenges, Next Steps

Brooke McCormick
Modern Medical Technologies | Image credit: Prostock-studio - stock.adobe.com
August 21st 2025

Using AI, Socioeconomic Factors to Predict Outcomes After Allo-SCT for AML

Laura Joszt, MA
Hidradenitis suppurativa. | Image Credit: Kristina Blokhin - stock.adobe.com
August 21st 2025

GLP-1s Show Promise for Patients With Hidradenitis Suppurativa and Obesity

Laura Joszt, MA

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2025 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo